CardioMEMs' 2nd chance with the FDA is good news for backer St. Jude Medical

September 9, 2013 by Arezu Sarvestani

The FDA's Circulatory System Devices Panel will in October reconsider CardioMEMs' once-rejected application for its Champion heart failure monitoring system, a potential boon for stakeholder St. Jude Medical.

FDA's decision to take another look at CardioMEMs has upsides for St. Jude Medical

Once-rejected CardioMEMs will get another shot at FDA approval for its Champion implantable heart failure monitoring systems when the agency's Circulatory System Devices Panel convenes next month, according to a notice in the Federal Register.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.